BIOMARIN PHARMACEUTICAL INC Quarterly Common Stock, Shares, Issued from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Biomarin Pharmaceutical Inc quarterly Common Stock, Shares, Issued history and growth rate from Q2 2010 to Q3 2024.
  • Biomarin Pharmaceutical Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 191M shares, a 1.18% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 191M +2.21M +1.18% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 190M +2.2M +1.17% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 190M +2.18M +1.16% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 189M +2.35M +1.26% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 188M +2.52M +1.35% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 188M +2.7M +1.46% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 188M +2.7M +1.46% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 186M +2.34M +1.27% Dec 31, 2022 10-K 2024-02-26
Q3 2022 186M +2.26M +1.23% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 185M +2.13M +1.16% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 185M +2.23M +1.22% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 184M +2.17M +1.2% Dec 31, 2021 10-K 2023-02-27
Q3 2021 184M +2.08M +1.14% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 183M +2.17M +1.2% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 183M +1.91M +1.06% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 182M +1.9M +1.06% Dec 31, 2020 10-K 2022-02-25
Q3 2020 181M +1.89M +1.05% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 181M +1.72M +0.96% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 181M +1.73M +0.97% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 180M +1.59M +0.89% Dec 31, 2019 10-K 2021-02-26
Q3 2019 180M +1.7M +0.96% Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 179M +1.93M +1.09% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 179M +2.38M +1.35% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 178M +2.41M +1.37% Dec 31, 2018 10-K 2020-02-27
Q3 2018 178M +2.41M +1.37% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 178M +2.26M +1.29% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 177M +3.35M +1.93% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 176M +3.2M +1.85% Dec 31, 2017 10-K 2019-02-28
Q3 2017 175M +3.8M +2.21% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 175M +12M +7.33% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 173M +11.1M +6.82% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 173M +11.1M +6.89% Dec 31, 2016 10-K 2018-02-26
Q3 2016 172M +10.5M +6.5% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 163M +2.27M +1.41% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 162M +1.96M +1.22% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 162M +12.4M +8.34% Dec 31, 2015 10-K 2017-02-27
Q3 2015 161M +13.8M +9.36% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 161M +13.9M +9.48% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 160M +14.5M +9.98% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 149M +5.63M +3.92% Dec 31, 2014 10-K 2016-02-29
Q3 2014 147M +5.23M +3.68% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 147M +7.02M +5.01% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 146M +6.87M +4.94% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 143M +17.7M +14% Dec 31, 2013 10-K 2015-03-02
Q3 2013 142M +18.4M +14.9% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 140M +16.8M +13.6% Jun 30, 2013 10-Q 2013-07-29
Q1 2013 139M +23.2M +20% Mar 31, 2013 10-Q 2013-04-29
Q4 2012 126M +11M +9.6% Dec 31, 2012 10-K 2014-02-26
Q3 2012 124M +9.64M +8.45% Sep 30, 2012 10-Q 2012-10-29
Q2 2012 123M +11.7M +10.5% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 116M +4.81M +4.34% Mar 31, 2012 10-Q 2012-04-30
Q4 2011 115M +4.16M +3.76% Dec 31, 2011 10-K 2013-02-26
Q3 2011 114M +11.7M +11.4% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 112M +9.55M +9.36% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 111M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 111M Dec 31, 2010 10-K 2012-02-22
Q3 2010 102M Sep 30, 2010 10-Q 2010-10-29
Q2 2010 102M Jun 30, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.